Osteopontin-a alters glucose homeostasis in anchorage-independent breast cancer cells

Cancer Letters

Volumn 344, Issue 1, 2014, Pages 47-53

  Shi, Zhanquan ^a   Mirza, Mana ^a   Wang, Bo ^b   Kennedy, Michael A ^b   Weber, Georg F ^a  

^a UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

^b MIAMI UNIVERSITY   (United States)

Author keywords

Cancer biology; Cytokine action; Glucose; Metabolic regulation; Metastasis

Indexed keywords

APOLIPOPROTEIN D; DNA; GLUCOSE; OSTEOPONTIN; OSTEOPONTIN A; OSTEOPONTIN C; PHOSPHORYLCHOLINE; SOMATOMEDIN BINDING PROTEIN 5; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERGLYCEMIA; METABOLIC REGULATION; OPNA GENE; OPNC GENE; PRIORITY JOURNAL; PROTEIN DNA BINDING; RNA SEQUENCE; RNA SPLICING;

CANCER BIOLOGY; CYTOKINE ACTION; GLUCOSE; METABOLIC REGULATION; METASTASIS;

BREAST NEOPLASMS; CELL ADHESION; GLUCOSE; HOMEOSTASIS; HUMANS; IMMUNOBLOTTING; MCF-7 CELLS; METABOLOMICS; NEOPLASM INVASIVENESS; OSTEOPONTIN; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84893682946     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.10.008     Document Type: Article

References (30)

1. Young M.F., Kerr J.M., Termine J.D., Wewer U.M., Wang M.G., McBride O.W., Fisher L.W. CDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 1990, 7:491-502.
2. Saitoh Y., Kuratsu J., Takeshima H., Yamamoto S., Ushio Y. Expression of osteopontin in human glioma. Its correlation with the malignancy. Lab. Invest. 1995, 72:55-63.
3. He B., Mirza M., Weber G.F. An osteopontin splice variant induces anchorage independence in human breast cancer cells. Oncogene 2006, 25:2192-2202.
4. Mirza M., Shaughnessy E., Hurley J.K., Vanpatten K.A., Pestano G.A., He B., Weber G.F. Osteopontin-c is a highly selective marker for breast cancer. Int. J. Cancer 2008, 122:889-897.
5. Weber G.F. Molecular mechanisms of metastasis. Cancer Lett. 2008, 270:181-190.
6. Weber G.F., Adler B., Ashkar S. Osteopontin in oxidative stress responses. Inflammatory Cells and Mediators in CNS Diseases 1999, 97-112. Amsterdam (Harwood Academic Publishers). R.R. Ruffolo Jr, G.Z. Feuerstein, A.J. Hunter, G. Poste, B.W. Metcalf (Eds.).
7. Shen H., Weber G.F. The osteopontin-c splice junction is important for anchorage-independent growth. Mol. Carcinog. 2013, (Epub ahead of print). 10.1002/mc.2199.
8. Folkman J., Moscona A. Role of cell shape in growth control. Nature 1978, 273:345-349.
9. Valentinis B., Morrione A., Peruzzi F., Prisco M., Reiss K., Baserga R. Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion. Oncogene 1999, 18:1827-1836.
10. Goodpaster A.M., Romick-Rosendale L.E., Kennedy M.A. Statistical significance analysis of nuclear magnetic resonance-based metabolomics data. Anal. Biochem. 2010, 401:134-143.
11. Goodpaster A.M., Kennedy M.A. Quantification and statistical significance analysis of group separation in NMR-based metabolomics studies. Chemom. Intel. Lab. Sys. 2011, 109:162-170.
12. Watanabe M., Sheriff S., Lewis K.B., Tinch S.L., Cho J., Balasubramaniam A., Kennedy M.A. HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines. Cancer Lett. 2012, 315:18-27.
13. Aguilera P., Ortega A. Stat3 participates in the metabotropic glutamate signaling pathway in Bergmann glial cells. Neurochem. Res. 1999, 24:981-986.
14. 2+ channel during cerebral ischemia in rat hippocampus. Neurosci. Lett. 2003, 345:61-64.
15. Yamashita S., Miyagi C., Carmany-Rampey A., Shimizu T., Fujii R., Schier A.F., Hirano T. Stat3 controls cell movements during zebrafish gastrulation. Dev. Cell. 2002, 2:363-375.
16. Kamakura S., Oishi K., Yoshimatsu T., Nakafuku M., Masuyama N., Gotoh Y. Hes binding to STAT3 mediates crosstalk between notch and JAK-STAT signalling. Nat. Cell. Biol. 2004, 6:547-554.
17. Monsalve E., Perez M.A., Rubio A., Ruiz-Hidalgo M.J., Baladron V., Garcia-Ramirez J.J., Gomez J.C., Laborda J., Diaz-Guerra M.J. Notch-1 up-regulation and signaling following macrophage activation modulates gene expression patterns known to affect antigen-presenting capacity and cytotoxic activity. J. Immunol. 2006, 176:5362-5373.
18. Chapman R.S., Lourenco P.C., Tonner E., Flint D.J., Selbert S., Takeda K., Akira S., Clarke A.R., Watson C.J. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev. 1999, 13:2604-2616.
19. Kojima H., Kunimoto H., Inoue T., Nakajima K. The STAT3-IGFBP5 axis is critical for IL-6/gp130-induced premature senescence in human fibroblasts. Cell. Cycle 2012, 11:730-739.
20. Shen L., Tso P., Woods S.C., Sakai R.R., Davidson W.S., Liu M. Hypothalamic apolipoprotein A-IV is regulated by leptin. Endocrinology 2007, 148:2681-2689.
21. Inoue H., Ogawa W., Ozaki M., Haga S., Matsumoto M., Furukawa K., Hashimoto N., Kido Y., Mori T., Sakaue H., Teshigawara K., Jin S., Iguchi H., Hiramatsu R., LeRoith D., Takeda K., Akira S., Kasuga M. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat. Med. 2004, 10:168-174.
22. Gleason C.E., Ning Y., Cominski T.P., Gupta R., Kaestner K.H., Pintar J.E., Birnbaum M.J. Role of insulin-like growth factor-binding protein 5 (IGFBP5) in organismal and pancreatic beta-cell growth. Mol. Endocrinol. 2010, 24:178-192.
23. Jiménez-Palomares M., Cózar-Castellano I., Ganfornina M.D., Sánchez D., Perdomo G. Genetic deficiency of apolipoprotein D in the mouse is associated with nonfasting hypertriglyceridemia and hyperinsulinemia. Metabolism 2011, 60:1767-1774.
24. Wang Y., Chen B., Shen D., Xue S. Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning. Heart Vessels 2009, 24:116-123.
25. Wu Y., Jiang P., Lin Y., Chen S., Lin N., Li J. Expression of phosphorylated-STAT3 and osteopontin and their correlation in melanoma. J. Huazhong Univ. Sci. Technol. Med. Sci. 2009, 29:246-250.
26. Behera R., Kumar V., Lohite K., Karnik S., Kundu G.C. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 2010, 31:192-200.
27. Zheng Y., Wang Z., Deng L., Yuan X., Ma Y., Zhang G., Gantier M.P., Liu J.P., Shen L., Xu D. Osteopontin promotes inflammation in patients with acute coronary syndrome through its activity on IL-17 producing cells. Eur. J. Immunol. 2012, 42:2803-2814.
28. Yeh M., Gharavi N.M., Choi J., Hsieh X., Reed E., Mouillesseaux K.P., Cole A.L., Reddy S.T., Berliner J.A. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J. Biol. Chem. 2004, 279:30175-30181.
29. Gharavi N.M., Alva J.A., Mouillesseaux K.P., Lai C., Yeh M., Yeung W., Johnson J., Szeto W.L., Hong L., Fishbein M., Wei L., Pfeffer L.M., Berliner J.A. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J. Biol. Chem. 2007, 282:31460-31468.
30. Hartung F., Weber G.F. RNA Blood levels of osteopontin splice variants are cancer markers. SpringerPlus 2013, 2:110.